Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema

Contact Dermatitis. 2019 Aug;81(2):145-147. doi: 10.1111/cod.13266. Epub 2019 Apr 10.
No abstract available

Keywords: allergic contact dermatitis; atopic dermatitis; case report; dupilumab; gloves; occupational; rubber.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Comorbidity
  • Dermatitis, Allergic Contact / diagnosis*
  • Dermatitis, Allergic Contact / epidemiology
  • Dermatitis, Allergic Contact / etiology
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / epidemiology
  • Dermatitis, Occupational / diagnosis*
  • Dermatitis, Occupational / epidemiology
  • Dermatitis, Occupational / etiology
  • Gloves, Surgical*
  • Guanidines / adverse effects*
  • Hand Dermatoses / chemically induced
  • Hand Dermatoses / diagnosis*
  • Hand Dermatoses / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Surgeons*

Substances

  • Antibodies, Monoclonal, Humanized
  • Guanidines
  • dupilumab
  • diphenylguanidine